Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials.

IF 2.8 4区医学 Q2 ONCOLOGY

Current Opinion in Oncology Pub Date : 2024-09-01 Epub Date: 2024-08-08 DOI:10.1097/CCO.0000000000001056

Martin F Fey, Seamus O'Reilly, Ahmad H Awada, John Crowley, Karen A Gelmon

引用次数: 0

查看原文本刊更多论文

在临床试验的安全性报告中认真使用 MedDRA 术语和首选术语。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Opinion in Oncology 医学-肿瘤学

CiteScore

6.10

自引率

2.90%

发文量

130

审稿时长

4-8 weeks

期刊介绍： With its easy-to-digest reviews on important advances in world literature, Current Opinion in Oncology offers expert evaluation on a wide range of topics from sixteen key disciplines including sarcomas, cancer biology, melanoma and endocrine tumors. Published bimonthly, each issue covers in detail the most pertinent advances in these fields from the previous year. This is supplemented by annotated references detailing the merits of the most important papers.